[1] Scandinavian Simvastatin Survival Study Group.Randomized trial of cholesterol lowering in4,444 patients with coronary heart disease:theScandinavian Simvastatin Survival Study(4S)[J].Lancet,1994,344(8934):1383-1389.[2] AMARENCO P,BOGOUSSLAVSKY J,CALLAHAN A 3RD,et al. High-dose atorvastatinafter stroke or transient ischemic attack[J]. N Engl J Med,2006,355(6):549-559.[3] RIDKER P M. Residual inflammatory risk:addressing the obverse side of the atherosclerosisprevention coin[J]. Eur Heart J,2016,37(22):1720-1722.[4] RIDKER P M,EVERETT B M,THUREN T,et al.Antiinflammatory Therapy with Canakinumab forAtherosclerotic Disease[J]. N Engl J Med,2017,377(12):1119-1131.